Comparison of the Effectiveness of an Adapted Physical Activity Program in a Dedicated Structure to a Self-program in Patients in Chronic Phase of a Stroke
Launched by ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE · Sep 25, 2023
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of two different physical activity programs for patients who are recovering from a stroke. Specifically, it compares a structured program led by professionals with a self-directed program where patients manage their own activities. The goal is to see which method helps patients increase their daily activity levels, measured by the number of steps they take each day. Additionally, the study will look at other important factors like walking ability, quality of life related to stroke, balance, and motivation to stay active.
To participate in this trial, you need to be over 18 years old and have had a stroke more than six months ago that has left you with some difficulty moving one side of your body (this is called spastic hemiparesis). You should be able to walk for at least six minutes on your own. However, if you need help to walk, have serious cognitive issues affecting your understanding, or have other health problems that would make physical activity unsafe, you would not be eligible to participate. If you join the study, you'll wear a device to track your steps and take part in various assessments to help researchers understand how the different programs affect your activity and overall well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age greater than 18 years
- • Left or right spastic hemiparesis after a first hemorrhagic or ischemic unilateral stroke older than 6 months
- • Walking possible for 6 minutes
- Exclusion Criteria:
- • Inability to walk without human assistance (with or without technical aids)
- • Cognitive impairment that compromises informed consent, including inability to understand the purpose and terms of the protocol
- • Inability to communicate
- • Presence of an additional neurological disorder
- • Medical conditions that contraindicate physical activity, such as an unbalanced cardiovascular or respiratory condition
- • Concurrent participation in another clinical research project
About Assistance Publique Hopitaux De Marseille
Assistance Publique - Hôpitaux de Marseille (AP-HM) is a leading public healthcare institution in France, dedicated to providing high-quality medical care and advancing research in various clinical fields. As a prominent sponsor of clinical trials, AP-HM is committed to fostering innovation and improving patient outcomes through rigorous scientific investigation. With a multidisciplinary approach, the institution collaborates with a network of healthcare professionals, researchers, and academic partners to facilitate cutting-edge studies that address critical health challenges. AP-HM's dedication to ethical standards and patient safety underscores its role as a trusted leader in clinical research and healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marseille, Bouches Du Rhône, France
Marseille, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported